Literature DB >> 7585149

Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro.

J P Maciejewski1, F F Weichold, N S Young, A Cara, D Zella, M S Reitz, R C Gallo.   

Abstract

We have tested a novel strategy of intracellular immunization to block human immunodeficiency virus (HIV) infection. The expression of a specific antibody within a cell was achieved by transduction of genes that encode for immunoglobulin chains with specificity to viral reverse transcriptase. We demonstrated that inhibition of this enzyme makes cells resistant to HIV infection by blocking an early stage of viral replication. If high efficiency transduction with a stable vector into lymphohaematopoietic stem cells or mature lymphocytes can be achieved, gene transfer-mediated intracellular immunization might be a feasible treatment strategy in AIDS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585149     DOI: 10.1038/nm0795-667

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  20 in total

1.  Intrabody construction and expression III: engineering hyperstable V(H) domains.

Authors:  P Wirtz; B Steipe
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 2.  Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics.

Authors:  Boon Chin Heng; David Michael Kemeny; Hua Liu; Tong Cao
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 3.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17.

Authors:  R Levin; A M Mhashilkar; T Dorfman; A Bukovsky; C Zani; J Bagley; J Hinkula; M Niedrig; J Albert; B Wahren; H G Göttlinger; W A Marasco
Journal:  Mol Med       Date:  1997-02       Impact factor: 6.354

5.  Gene therapy for HIV infections: Intracellular immunization.

Authors:  A Piché
Journal:  Can J Infect Dis       Date:  1999-07

6.  Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family.

Authors:  N Gargano; S Biocca; A Bradbury; A Cattaneo
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively.

Authors:  Z Gu; X Li; Y Quan; M A Parniak; M A Wainberg
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

Authors:  F Shaheen; L Duan; M Zhu; O Bagasra; R J Pomerantz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  E. coli expression of a soluble, active single-chain antibody variable fragment containing a nuclear localization signal.

Authors:  Hairong Xiong; Shuyi Li; Zhanqiu Yang; Richard R Burgess; William S Dynan
Journal:  Protein Expr Purif       Date:  2009-03-10       Impact factor: 1.650

10.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.